Cancer Diagnostics Market Size, Share & Industry Analysis, By Product (Instruments and Assay Kits & Reagents), By Technique (Immunohistochemistry (IHC), Immunoassays, Molecular Diagnostics [Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), In-situ Hybridization (ISH), and Others], and Others), By Type (Tissue Biopsy and Liquid Biopsy), By Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, and Others), By End-user (Hospitals & Clinics, Clinical Laboratories, and Others), and Regional Forecast, 2024-2032

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI110706

THANK YOU

FOR YOUR INTEREST IN OUR REPORT

Are you interested in exploring our consulting services?

I want to learn more about:

Competitive Intelligence Opportunity Assessment Distribution & Supply Chain Analysis Book a consultation to discuss your needs

Market Entry Strategy Go-to-market Strategy Others (Please specify)

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
Key Insights
1. Prevalence of Key Cancer, by Countries/Region in 2023
2. New Product Launches by Key Players
3. Recent Industry Developments - Mergers & Acquisitions
4. Overview of Healthcare Expenditure by Key Countries
5. Technological Advancements, Diagnostic Instruments & Kits
6. Impact of COVID-19 on the Cancer Diagnostics Market
Global Cancer Diagnostics Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product
  1. Instruments
  2. Assay Kits & Reagents
2. Market Analysis, Insights and Forecast – By Technique
  1. Immunohistochemistry (IHC)
  2. Immunoassays
  3. Molecular Diagnostics
    1. Next Generation Sequencing (NGS)
    2. Polymerase Chain Reaction (PCR)
    3. In-situ Hybridization (ISH)
    4. Others
  4. Others
3. Market Analysis, Insights and Forecast – By Type
  1. Tissue Biopsy
  2. Liquid Biopsy
4. Market Analysis, Insights and Forecast – By Cancer Type
  1. Lung Cancer
  2. Breast Cancer
  3. Colorectal Cancer
  4. Prostate Cancer
  5. Others
5. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Clinics
  2. Clinical Laboratories
  3. Others
6. Market Analysis, Insights and Forecast – By Geography
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Cancer Diagnostics Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product
  1. Instruments
  2. Assay Kits & Reagents
2. Market Analysis, Insights and Forecast – By Technique
  1. Immunohistochemistry (IHC)
  2. Immunoassays
  3. Molecular Diagnostics
    1. Next Generation Sequencing (NGS)
    2. Polymerase Chain Reaction (PCR)
    3. In-situ Hybridization (ISH)
    4. Others
  4. Others
3. Market Analysis, Insights and Forecast – By Type
  1. Tissue Biopsy
  2. Liquid Biopsy
4. Market Analysis, Insights and Forecast – By Cancer Type
  1. Lung Cancer
  2. Breast Cancer
  3. Colorectal Cancer
  4. Prostate Cancer
  5. Others
5. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Clinics
  2. Clinical Laboratories
  3. Others
6. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Cancer Diagnostics Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product
  1. Instruments
  2. Assay Kits & Reagents
2. Market Analysis, Insights and Forecast – By Technique
  1. Immunohistochemistry (IHC)
  2. Immunoassays
  3. Molecular Diagnostics
    1. Next Generation Sequencing (NGS)
    2. Polymerase Chain Reaction (PCR)
    3. In-situ Hybridization (ISH)
    4. Others
  4. Others
3. Market Analysis, Insights and Forecast – By Type
  1. Tissue Biopsy
  2. Liquid Biopsy
4. Market Analysis, Insights and Forecast – By Cancer Type
  1. Lung Cancer
  2. Breast Cancer
  3. Colorectal Cancer
  4. Prostate Cancer
  5. Others
5. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Clinics
  2. Clinical Laboratories
  3. Others
6. Market Analysis, Insights and Forecast – By Country/ Sub-region
  1. U.K.
  2. Germany
  3. France
  4. Spain
  5. Italy
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Cancer Diagnostics Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product
  1. Instruments
  2. Assay Kits & Reagents
2. Market Analysis, Insights and Forecast – By Technique
  1. Immunohistochemistry (IHC)
  2. Immunoassays
  3. Molecular Diagnostics
    1. Next Generation Sequencing (NGS)
    2. Polymerase Chain Reaction (PCR)
    3. In-situ Hybridization (ISH)
    4. Others
  4. Others
3. Market Analysis, Insights and Forecast – By Type
  1. Tissue Biopsy
  2. Liquid Biopsy
4. Market Analysis, Insights and Forecast – By Cancer Type
  1. Lung Cancer
  2. Breast Cancer
  3. Colorectal Cancer
  4. Prostate Cancer
  5. Others
5. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Clinics
  2. Clinical Laboratories
  3. Others
6. Market Analysis, Insights and Forecast – By Country/ Sub-region
  1. Japan
  2. China
  3. Australia
  4. India
  5. Southeast Asia
  6. Rest of Asia Pacific
Latin America Cancer Diagnostics Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product
  1. Instruments
  2. Assay Kits & Reagents
2. Market Analysis, Insights and Forecast – By Technique
  1. Immunohistochemistry (IHC)
  2. Immunoassays
  3. Molecular Diagnostics
    1. Next Generation Sequencing (NGS)
    2. Polymerase Chain Reaction (PCR)
    3. In-situ Hybridization (ISH)
    4. Others
  4. Others
3. Market Analysis, Insights and Forecast – By Type
  1. Tissue Biopsy
  2. Liquid Biopsy
4. Market Analysis, Insights and Forecast – By Cancer Type
  1. Lung Cancer
  2. Breast Cancer
  3. Colorectal Cancer
  4. Prostate Cancer
  5. Others
5. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Clinics
  2. Clinical Laboratories
  3. Others
6. Market Analysis, Insights and Forecast – By Country/ Sub-region
  1. Brazil
  2. Mexico
  3. Rest of Latin America
Middle East & Africa Cancer Diagnostics Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Product
  1. Instruments
  2. Assay Kits & Reagents
2. Market Analysis, Insights and Forecast – By Technique
  1. Immunohistochemistry (IHC)
  2. Immunoassays
  3. Molecular Diagnostics
    1. Next Generation Sequencing (NGS)
    2. Polymerase Chain Reaction (PCR)
    3. In-situ Hybridization (ISH)
    4. Others
  4. Others
3. Market Analysis, Insights and Forecast – By Type
  1. Tissue Biopsy
  2. Liquid Biopsy
4. Market Analysis, Insights and Forecast – By Cancer Type
  1. Lung Cancer
  2. Breast Cancer
  3. Colorectal Cancer
  4. Prostate Cancer
  5. Others
5. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Clinics
  2. Clinical Laboratories
  3. Others
6. Market Analysis, Insights and Forecast – By Country/ Sub-region
  1. South Africa
  2. GCC
  3. Rest of Middle East & Africa
Competitive Analysis
1. Global Market Share Analysis (2023)
2. Profiles of Players Operating in the Market
  1. F. Hoffmann-La Roche Ltd
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  2. Thermo Fisher Scientific Inc.
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  3. Abbott
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  4. Illumina, Inc.
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  5. GE Healthcare
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  6. BD
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  7. bioMérieux SA
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  8. Myriad Genetics, Inc
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  9. Bio-Rad Laboratories, Inc.
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  10. QIAGEN
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)

Read Less

List of Figures

Figure 1: Global Cancer Diagnostics Market Revenue Breakdown (USD billion, %) by Region, 2023 & 2032

Figure 2: Global Cancer Diagnostics Market Value Share (%), by Product, 2023 & 2032

Figure 3: Global Cancer Diagnostics Market Value Share (%), by Technique, 2023 & 2032

Figure 4: Global Cancer Diagnostics Market Value Share (%), by Type, 2023 & 2032

Figure 5: Global Cancer Diagnostics Market Value Share (%), by Cancer Type, 2023 & 2032

Figure 6: Global Cancer Diagnostics Market Value Share (%), by End-user, 2023 & 2032

Figure 7: Global Cancer Diagnostics Market Value (USD billion), by Region, 2023 & 2032

Figure 8: North America Cancer Diagnostics Market Value (USD billion), by Product, 2023 & 2032

Figure 9: North America Cancer Diagnostics Market Value Share (%), by Product, 2023

Figure 10: North America Cancer Diagnostics Market Value (USD billion), by Technique, 2023 & 2032

Figure 11: North America Cancer Diagnostics Market Value Share (%), by Technique, 2023

Figure 12: North America Cancer Diagnostics Market Value (USD billion), by Type, 2023 & 2032

Figure 13: North America Cancer Diagnostics Market Value Share (%), by Type, 2023

Figure 14: North America Cancer Diagnostics Market Value (USD billion), by Cancer Type, 2023 & 2032

Figure 15: North America Cancer Diagnostics Market Value Share (%), by Cancer Type, 2023

Figure 16: North America Cancer Diagnostics Market Value (USD billion), by End-user, 2023 & 2032

Figure 17: North America Cancer Diagnostics Market Value Share (%), by End-user, 2023

Figure 18: North America Cancer Diagnostics Market Value (USD billion), By Country, 2023 & 2032

Figure 19: North America Cancer Diagnostics Market Value Share (%), By Country, 2023

Figure 20: Europe Cancer Diagnostics Market Value (USD billion), by Product, 2023 & 2032

Figure 21: Europe Cancer Diagnostics Market Value Share (%), by Product, 2023

Figure 22: Europe Cancer Diagnostics Market Value (USD billion), by Technique, 2023 & 2032

Figure 23: Europe Cancer Diagnostics Market Value Share (%), by Technique, 2023

Figure 24: Europe Cancer Diagnostics Market Value (USD billion), by Type, 2023 & 2032

Figure 25: Europe Cancer Diagnostics Market Value Share (%), by Type, 2023

Figure 26: Europe Cancer Diagnostics Market Value (USD billion), by Cancer Type, 2023 & 2032

Figure 27: Europe Cancer Diagnostics Market Value Share (%), by Cancer Type, 2023

Figure 28: Europe Cancer Diagnostics Market Value (USD billion), by End-user, 2023 & 2032

Figure 29: Europe Cancer Diagnostics Market Value Share (%), by End-user, 2023

Figure 30: Europe Cancer Diagnostics Market Value (USD billion), By Country/ Sub-region, 2023 & 2032

Figure 31: Europe Cancer Diagnostics Market Value Share (%), By Country/ Sub-region, 2023

Figure 32: Asia Pacific Cancer Diagnostics Market Value (USD billion), by Product, 2023 & 2032

Figure 33: Asia Pacific Cancer Diagnostics Market Value Share (%), by Product, 2023

Figure 34: Asia Pacific Cancer Diagnostics Market Value (USD billion), by Technique, 2023 & 2032

Figure 35: Asia Pacific Cancer Diagnostics Market Value Share (%), by Technique, 2023

Figure 36: Asia Pacific Cancer Diagnostics Market Value (USD billion), by Type, 2023 & 2032

Figure 37: Asia Pacific Cancer Diagnostics Market Value Share (%), by Type, 2023

Figure 38: Asia Pacific Cancer Diagnostics Market Value (USD billion), by Cancer Type, 2023 & 2032

Figure 39: Asia Pacific Cancer Diagnostics Market Value Share (%), by Cancer Type, 2023

Figure 40: Asia Pacific Cancer Diagnostics Market Value (USD billion), by End-user, 2023 & 2032

Figure 41: Asia Pacific Cancer Diagnostics Market Value Share (%), by End-user, 2023

Figure 42: Asia Pacific Cancer Diagnostics Market Value (USD billion), By Country/ Sub-region, 2023 & 2032

Figure 43: Asia Pacific Cancer Diagnostics Market Value Share (%), By Country/ Sub-region, 2023

Figure 44: Latin America Cancer Diagnostics Market Value (USD billion), by Product, 2023 & 2032

Figure 45: Latin America Cancer Diagnostics Market Value Share (%), by Product, 2023

Figure 46: Latin America Cancer Diagnostics Market Value (USD billion), by Technique, 2023 & 2032

Figure 47: Latin America Cancer Diagnostics Market Value Share (%), by Technique, 2023

Figure 48: Latin America Cancer Diagnostics Market Value (USD billion), by Type, 2023 & 2032

Figure 49: Latin America Cancer Diagnostics Market Value Share (%), by Type, 2023

Figure 50: Latin America Cancer Diagnostics Market Value (USD billion), by Cancer Type, 2023 & 2032

Figure 51: Latin America Cancer Diagnostics Market Value Share (%), by Cancer Type, 2023

Figure 52: Latin America Cancer Diagnostics Market Value (USD billion), by End-user, 2023 & 2032

Figure 53: Latin America Cancer Diagnostics Market Value Share (%), by End-user, 2023

Figure 54: Latin America Cancer Diagnostics Market Value (USD billion), By Country/ Sub-region, 2023 & 2032

Figure 55: Latin America Cancer Diagnostics Market Value Share (%), By Country/ Sub-region, 2023

Figure 56: Middle East & Africa Cancer Diagnostics Market Value (USD billion), by Product, 2023 & 2032

Figure 57: Middle East & Africa Cancer Diagnostics Market Value Share (%), by Product, 2023

Figure 58: Middle East & Africa Cancer Diagnostics Market Value (USD billion), by Technique, 2023 & 2032

Figure 59: Middle East & Africa Cancer Diagnostics Market Value Share (%), by Technique, 2023

Figure 60: Middle East & Africa Cancer Diagnostics Market Value (USD billion), by Type, 2023 & 2032

Figure 61: Middle East & Africa Cancer Diagnostics Market Value Share (%), by Type, 2023

Figure 62: Middle East & Africa Cancer Diagnostics Market Value (USD billion), by Cancer Type, 2023 & 2032

Figure 63: Middle East & Africa Cancer Diagnostics Market Value Share (%), by Cancer Type, 2023

Figure 64: Middle East & Africa Cancer Diagnostics Market Value (USD billion), by End-user, 2023 & 2032

Figure 65: Middle East & Africa Cancer Diagnostics Market Value Share (%), by End-user, 2023

Figure 66: Middle East & Africa Cancer Diagnostics Market Value (USD billion), By Country/ Sub-region, 2023 & 2032

Figure 67: Middle East & Africa Cancer Diagnostics Market Value Share (%), By Country/ Sub-region, 2023

Figure 68: Global Cancer Diagnostics Market Share (%), By Company, 2023

List of Tables

Table 1: Global Cancer Diagnostics Market Revenue (USD billion) Forecast, by Product, 2019-2032

Table 2: Global Cancer Diagnostics Market Revenue (USD billion) Forecast, by Technique, 2019-2032

Table 3: Global Cancer Diagnostics Market Revenue (USD billion) Forecast, by Molecular Diagnostics, 2019-2032

Table 4: Global Cancer Diagnostics Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 5: Global Cancer Diagnostics Market Revenue (USD billion) Forecast, by Cancer Type, 2019-2032

Table 6: Global Cancer Diagnostics Market Revenue (USD billion) Forecast, by End-user, 2019-2032

Table 7: Global Cancer Diagnostics Market Revenue (USD billion) Forecast, by Region, 2019-2032

Table 8: North America Cancer Diagnostics Market Revenue (USD billion) Forecast, by Product, 2019-2032

Table 9: North America Cancer Diagnostics Market Revenue (USD billion) Forecast, by Technique, 2019-2032

Table 10: North America Cancer Diagnostics Market Revenue (USD billion) Forecast, by Molecular Diagnostics, 2019-2032

Table 11: North America Cancer Diagnostics Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 12: North America Cancer Diagnostics Market Revenue (USD billion) Forecast, by Cancer Type, 2019-2032

Table 13: North America Cancer Diagnostics Market Revenue (USD billion) Forecast, by End-user, 2019-2032

Table 14: North America Cancer Diagnostics Market Revenue (USD billion) Forecast, By Country, 2019-2032

Table 15: Europe Cancer Diagnostics Market Revenue (USD billion) Forecast, by Product, 2019-2032

Table 16: Europe Cancer Diagnostics Market Revenue (USD billion) Forecast, by Technique, 2019-2032

Table 17: Europe Cancer Diagnostics Market Revenue (USD billion) Forecast, by Molecular Diagnostics, 2019-2032

Table 18: Europe Cancer Diagnostics Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 19: Europe Cancer Diagnostics Market Revenue (USD billion) Forecast, by Cancer Type, 2019-2032

Table 20: Europe Cancer Diagnostics Market Revenue (USD billion) Forecast, by End-user, 2019-2032

Table 21: Europe Cancer Diagnostics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 22: Asia Pacific Cancer Diagnostics Market Revenue (USD billion) Forecast, by Product, 2019-2032

Table 23: Asia Pacific Cancer Diagnostics Market Revenue (USD billion) Forecast, by Technique, 2019-2032

Table 24: Asia Pacific Cancer Diagnostics Market Revenue (USD billion) Forecast, by Molecular Diagnostics, 2019-2032

Table 25: Asia Pacific Cancer Diagnostics Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 26: Asia Pacific Cancer Diagnostics Market Revenue (USD billion) Forecast, by Cancer Type, 2019-2032

Table 27: Asia Pacific Cancer Diagnostics Market Revenue (USD billion) Forecast, by End-user, 2019-2032

Table 28: Asia Pacific Cancer Diagnostics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 29: Latin America Cancer Diagnostics Market Revenue (USD billion) Forecast, by Product, 2019-2032

Table 30: Latin America Cancer Diagnostics Market Revenue (USD billion) Forecast, by Technique, 2019-2032

Table 31: Latin America Cancer Diagnostics Market Revenue (USD billion) Forecast, by Molecular Diagnostics, 2019-2032

Table 32: Latin America Cancer Diagnostics Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 33: Latin America Cancer Diagnostics Market Revenue (USD billion) Forecast, by Cancer Type, 2019-2032

Table 34: Latin America Cancer Diagnostics Market Revenue (USD billion) Forecast, by End-user, 2019-2032

Table 35: Latin America Cancer Diagnostics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 36: Middle East & Africa Cancer Diagnostics Market Revenue (USD billion) Forecast, by Product, 2019-2032

Table 37: Middle East & Africa Cancer Diagnostics Market Revenue (USD billion) Forecast, by Technique, 2019-2032

Table 38: Middle East & Africa Cancer Diagnostics Market Revenue (USD billion) Forecast, by Molecular Diagnostics, 2019-2032

Table 39: Middle East & Africa Cancer Diagnostics Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 40: Middle East & Africa Cancer Diagnostics Market Revenue (USD billion) Forecast, by Cancer Type, 2019-2032

Table 41: Middle East & Africa Cancer Diagnostics Market Revenue (USD billion) Forecast, by End-user, 2019-2032

Table 42: Middle East & Africa Cancer Diagnostics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

STUDY PERIOD: 2019-2032
BASE YEAR:2023
HISTORICAL DATA: 2019-2022
NO OF PAGES: 130

Multi-report Purchase Plan

Healthcare Clients

Related Reports

Get in Touch with Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

+91 744 740 1245 (APAC)
[email protected]

"United States Medical Devices Market!"

Our team will share the report with you shortly.

We appreciate your interest!

THANK YOU

FOR YOUR INTEREST IN OUR REPORT

Table of Content

List of Figures

List of Tables